1st Biosafety Summer School
Title: Biological therapies and vaccines: safety issues, physiological and immunological mechanisms
Summer School for PhD students and young researchers. The aim of this two-day summer school is to provide a practical, hands-on experience of biosafety issues beyond the university level.
Date: 15-16. 06. 2021.
Platform: Online, Zoom (language: English)
More information about lectures → Summer School programme
Lectures
- Nadja Prang (TecoBiosciences GmbH, Landshut, Germany): Biosafety markers
- János Szebeni, project leader (Nanomedicine Research and Education Center, Institute of Translational Medicine,
Semmelweis University, Budapest, Hungary) : Hypersensitivity to Nano-biopharmaceuticals and COVID vaccines - László Dézsi (Nanomedicine Research and Education Center, Institute of Translational Medicine,
Semmelweis University, Budapest, Hungary): Animal models of drug-induced hypersensitivity - Gaston Fuentes Estevez (Translational Nanobiomaterials and Imaging Leiden University Medical Center, Leiden, The Netherlands): Biosafety of Nanobiomaterials
- Karolina Pircs (Institute of Translational Medicine, Semmelweis University, Budapest, Hungary): Direct neural conversion: New possibilities to model late onset neurodegenerative diseases
- Zoltán Benyó (Institute of Translational Medicine, Semmelweis University, Budapest, Hungary): Molecular mechanisms of niacin-induced flushing
- Miklós Kellermayer (Department of Biophysics and Radiation Biology, Faculty of Medicine, Semmelweis
University, Budapest, Hungary): Biophysical virology of SARS-CoV-2 - Marina A. Dobrovolskaia (Nanotechnology Characterization Laboratory, Frederick National Laboratory for
Cancer Research, National Cancer Institute, Frederick MD, USA): Preclinical immunological characterization of nanoparticles - Tamás Fülöp (Tecodevelopment GmbH, Rheinbach, Germany): Complement immunoassay development for biosafety research
- Gábor Szénási (Institute of Translational Medicine Semmelweis University, Budapest, Hungary): Murine models of liposome reactions: technical challenges and mechanisms
- Daan J.A. Crommelin (Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht
University, the Netherlands): Pharmaceutical aspects of biologicals/vaccines: characterization, critical quality
attributes, stability - Ákos Koller (Institute of Translational Medicine, Semmelweis University, Budapest, Hungary; New York Medical College, NY, USA): Nitric oxide: a basic science hero, but what about safety and therapy?